TP53 and familial pancreatic carcinoma: Although this mechanism could explain, at least partly, the statin sensitivity of the human pancreatic cancer cells used in this study (PANC-1 and MiaPaCa-2) which contain mutated TP53, the KC cells express wild type p53.